Epibiotech Co., Ltd. (XKON:446440)
South Korea · Delayed Price · Currency is KRW 9,540.00
-1,680.00 (-14.97%)
At close: Nov 12, 2026
Epibiotech Revenue
In the year 2022, Epibiotech had annual revenue of 449.62M KRW with 15.93% growth. That makes Epibiotech the 44,973rd largest company in the world by revenue and 2,605th in South Korea.
Revenue
449.62M
Revenue Growth
+15.93%
P/S Ratio
48.95
Revenue / Employee
n/a
Employees
n/a
Market Cap
22.01B
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2022 | 449.62M | 61.77M | 15.93% |
| Dec 31, 2021 | 387.85M | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. It does not take any expenses into account and is therefore different from profits.